Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects.
about
Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitisHaemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitisVaccination against respiratory Pseudomonas aeruginosa infectionProtection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.Global challenge of multidrug-resistant Acinetobacter baumanniiAn Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.Needle-free vaccine delivery.Six costs of immunity to gastrointestinal nematode infections.Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infectionRecent developments for Pseudomonas vaccines.Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.Effects of antigen-expressing immunostimulatory liposomes on chemotaxis and maturation of dendritic cells in vitro and in human skin explants.Cross-reaction between proteins of Larrea divaricata Cav. (jarilla) and proteins of Gram-negative bacteria.
P2860
Q24234713-CBE166A7-25A2-4577-AD9B-15BE71B9B4B7Q24244074-3EFFAE9D-8B4C-4259-A016-628E1C1F321DQ26824014-B7BADAAB-5618-43DA-BE4E-43E9D6E47B8BQ33523622-0B4483F0-7D28-40A0-BE30-9D3A3B9DECB5Q34271496-ACC3E1A7-81AA-4884-87AF-DBBAF9330E88Q36095081-F9759F8F-44E3-4082-8FF9-8A6084147A58Q36628209-EC5D2707-34BE-40D7-94C1-1730576D3E4EQ36945838-B4B84A44-77EB-4558-90BE-7B26489E3B55Q37054414-F5163994-80B3-44F7-983A-E29A0C0526EFQ37478266-48B358C7-C89D-43BA-88AD-F929718F5AE1Q37937369-D71515C7-FBCA-4949-95E1-5B0D7270CE08Q38941665-C5B26713-5276-49B8-9B9C-B56D8DFFB70FQ39090799-7F31436B-2837-4925-9E95-55ECFFC7DDAEQ54396231-E80B925A-A773-4C69-886E-B6A7DF8D7913
P2860
Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Safety and immunogenicity of a ...... red to healthy human subjects.
@ast
Safety and immunogenicity of a ...... red to healthy human subjects.
@en
Safety and immunogenicity of a ...... red to healthy human subjects.
@nl
type
label
Safety and immunogenicity of a ...... red to healthy human subjects.
@ast
Safety and immunogenicity of a ...... red to healthy human subjects.
@en
Safety and immunogenicity of a ...... red to healthy human subjects.
@nl
prefLabel
Safety and immunogenicity of a ...... red to healthy human subjects.
@ast
Safety and immunogenicity of a ...... red to healthy human subjects.
@en
Safety and immunogenicity of a ...... red to healthy human subjects.
@nl
P2093
P2860
P1476
Safety and immunogenicity of a ...... red to healthy human subjects.
@en
P2093
Allan W Cripps
Duncan Croft
Joanne K Marjason
Keith Peek
Kevin Vento
Lis Sedlak-Weinstein
Madonna E McIntyre
Margaret Dunkley
Phil Sizer
P2860
P304
P356
10.1128/IAI.74.2.968-974.2006
P407
P577
2006-02-01T00:00:00Z